BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7689754)

  • 1. Effectiveness of aprotinin in orthotopic liver transplantation.
    Suárez M; Sangro B; Herrero JI; Picardi A; Páramo JA; Quiroga J; Pardo F; Cienfuegos J; Carrera J; Hidalgo F
    Semin Thromb Hemost; 1993; 19(3):292-6. PubMed ID: 7689754
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
    Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
    Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
    [No Abstract]   [Full Text] [Related]  

  • 3. Does aprotinin really reduce blood loss in orthotopic liver transplantation?
    Groh J; Welte M; Azad SC; Anthuber M; Haller M; Kratzer MA
    Semin Thromb Hemost; 1993; 19(3):306-8. PubMed ID: 7689758
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of two different dosages of aprotonin on perioperative blood loss during liver transplantation.
    Ickx B; Pradier O; DeGroote F; Hendrice C; Toungouz M; Vandestadt J; Gelin M; Capel P
    Semin Thromb Hemost; 1993; 19(3):300-1. PubMed ID: 7689756
    [No Abstract]   [Full Text] [Related]  

  • 5. Aprotinin in orthotopic liver transplantation.
    Bechstein WO; Riess H; Blumhardt G; Himmelreich G; Jochum M; Gerlach H; Rossaint R; Keck H; Neuhaus P
    Semin Thromb Hemost; 1993; 19(3):262-7. PubMed ID: 7689751
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of leukocytes in hemostasis during orthotopic liver transplantation.
    Riess H; Jochum M; Machleidt W; Himmelreich G; Bechstein WO; Muser M; Neuhaus P; Roissant R; Huhn D
    Semin Thromb Hemost; 1993; 19(3):197-208. PubMed ID: 7689749
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
    Azad SC; Kratzer MA; Groh J; Welte M; Haller M; Pratschke E
    Semin Thromb Hemost; 1993; 19(3):233-7. PubMed ID: 8362253
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor XIII activity during orthotopic liver transplantation.
    Himmelreich G; Müller C; Isenberg C; Bechstein WO; Roissant R; Riess H
    Semin Thromb Hemost; 1993; 19(3):243-5. PubMed ID: 7689750
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of aprotinin on coagulation parameters in liver transplantation.
    Welte M; Groh J; Azad S; Anthuber M; Haller M; Kratzer MA
    Semin Thromb Hemost; 1993; 19(3):297-9. PubMed ID: 7689755
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation.
    Himmelreich G; Hundt K; Bechstein WO; Rossaint R; Neuhaus P; Riess H
    Semin Thromb Hemost; 1993; 19(3):273-8. PubMed ID: 7689752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
    Monedero P; Páramo JA; Carrascosa F; Herrero JI; Hidalgo F; Iribarren MJ; García-Pedrajas F
    Rev Esp Anestesiol Reanim; 1995 Mar; 42(3):82-6. PubMed ID: 7539932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
    Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
    Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.
    Himmelreich G; Dooijewaard G; Breinl P; Bechstein WO; Blumhardt G; Kluft C; Riess H
    Semin Thromb Hemost; 1993; 19(3):311-4. PubMed ID: 7689759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation.
    Patrassi GM; Viero M; Sartori MT; De Silvestro G; Rossaro L; Burra P; Nolli ML; Piccinni P; Bassi N
    Transfusion; 1994 Jun; 34(6):507-11. PubMed ID: 7517586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aprotinin in orthotopic liver transplantation].
    García Huete L; Sabaté Pes A
    Med Clin (Barc); 1997 Mar; 108(11):439. PubMed ID: 9213647
    [No Abstract]   [Full Text] [Related]  

  • 16. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation.
    Mallett SV; Cox D; Burroughs AK; Rolles K
    Lancet; 1990 Oct; 336(8719):886-7. PubMed ID: 1699096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aprotinin in the control of surgical hemorrhage].
    Rocha E; Antonio Páramo J; Hermida J
    Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights.
    Porte RJ
    Semin Thromb Hemost; 1993; 19(3):191-6. PubMed ID: 8362248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of aprotinin in cardiovascular surgery].
    Colorio C; Carreras LO
    Sangre (Barc); 1995 Jun; 40(3):207-11. PubMed ID: 7570273
    [No Abstract]   [Full Text] [Related]  

  • 20. "Goal-directed" transfusion management leads to distinct reduction of fluid requirement in liver transplantation.
    Gerlach H; Rossaint R; Bechstein WO; Blumhardt G; Neuhaus P; Falke K
    Semin Thromb Hemost; 1993; 19(3):282-5. PubMed ID: 7689753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.